TARSONSTarsons Products Ltd.

₹297.55-0.32%

Market Cap

₹1,585.28 Cr

Stock P/E

57.57

ROCE

7.04%

ROE

4.79%

Book Value

₹118.78

Financials

YoY Net Sales

EPS Growth

Operating Margin

No recent news available for this stock.

Holdings

Distribution

Promoter

Institution

Public

Others

POSITIVES

•
Tarsons posted 7% YoY growth in consolidated revenues for Q4 FY25.
•
Expansion into cell culture and bioprocess lines could nearly double Tarsons' addressable market.

NEGATIVES

•
Nerbe’s margin drag from its trading-focused business model lowers consolidated margins.
•
Nerbe’s turnover has been flat (~INR 20 crores) and provides little EBITDA in the near term.

Peer comparison data is not available for this stock.